Post Traumatic Stress Disorder ( Ptsd )

Studying the brain has been an affective result in finding out the various neurochemicals that are involved with PTSD. Brain imaging systems nowadays focus on two brain structures, the amygdala and the hippocampus. The amygdala is involved with how we learn about our fear and hippocampus plays a role with our memory formation. Some research focuses on a hormonal system known as hypothalamic-pituitary

This paper explores post-traumatic stress and how it is seen as a disorder. Post-traumatic stress can manifest into post-traumatic stress disorder. According to Sareen (2014), Post-traumatic stress disorder is defined in the Diagnostic and Statistical Manual of Mental Disorders, or DSM-5 as having 4 core features that are as follows. First, the person must witness or experience a stressful event. Secondly, the person or persons would re-experience symptoms of the event that include nightmares and/or flashbacks. The person or persons would also have hyper arousal symptoms, such as concentrations problems, irritability, and sleep disturbance. The final core feature dictates

Post-traumatic stress disorder (PTSD) is a relatively new diagnosis that was associated with survivors of war when it was first introduced. Its diagnosis was met largely with skepticism and dismissal by the public of the validity of the illness. PTSD was only widely accepted when it was included as a diagnosis in 1980 in the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III) of the American Psychiatric Association. PTSD is a complex mental disorder that develops in response to exposure to a severe traumatic event that stems a cluster of symptoms. Being afflicted with the disorder is debilitating, disrupting an individual’s ability to function and perform the most basic tasks.

Sullivan, Gregory. "Vetting PTSD." Nature Medicine 17.9 (2011): 1031. Health Reference Center Academic. Web. 21 Apr.

Although posttraumatic stress disorder (PTSD) is sometimes considered to be a relatively new diagnosis, as the name first appeared in 1980, the concept of the disorder has a very long history. That history has often been linked to the history of war, but the disorder has also been frequently described in civilian settings involving natural disasters, mass catastrophes, and serious accidental injuries. The diagnosis first appeared in the official nomenclature when Diagnostic and Statistical Manual of Mental Disorders (DSM)-I was published in 1952 under the name gross stress reaction. It was omitted, however, in the next edition in 1968, after a long

PTSD is only now being recognized as a legitimate disease. When symptoms, of what is now PTSD, began showing up on the battlefields in the 1800’s, doctors of the military had “begun to diagnose soldiers with ‘exhaustion’” (Eagan,p. 360). Medicine of the time was about physical disorders. Doctors paid little to no attention to the enigmatic field of mind-body medicine. “Exhaustion” was the diagnosis of a “mental shutdown” caused by trauma (Eagan,p. 360). Diagnosing soldiers with ‘exhaustion’ was the military’s and

Post-Traumatic stress disorder, commonly known as PTSD, is on a rise in our country and expected to rise more in the coming years (Iribarren, Prolo, Neagos, & Chiappelli, 2005). PTSD is a psychiatric disorder than can result from the experience or witnessing of traumatic or life-threatening events (Iribarren, Prolo, Neagos, & Chiappelli, 2005). According to the Evidence based article examples of PTSD are terrorist attack, violent crime and abuse, military combat, natural disasters, serious accidents or violent personal assaults (Iribarren, Prolo, Neagos, & Chiappelli, 2005). PTSD has also been liked to possible exposure to environmental toxins such as Agent Orange or electromagnetic radiation (Iribarren, Prolo, Neagos, & Chiappelli, 2005).

Two selective serotonin reuptake inhibitors (SSRIs), paroxetine and sertraline, have been approved by the FDA for the treatment of PTSD. However, the results of the effectiveness of pharmacology in double-blind, placebo controlled studies were not greater than PE and CPT or they were insignificant (Peterson et al., 2011).

At least 50% of all adults and children are exposed to a psychologically traumatic event (such as a life-threatening assault or accident, humanmade or natural disaster, or war). As many as 67% of trauma survivors experience lasting psychosocial impairment, including post-traumatic stress disorder (PTSD); panic, phobic, or generalized anxiety disorders; depression; or substance abuse.(Van der Kolk, et al, 1994) Symptoms of PTSD include persistent involuntary re-experiencing of traumatic distress, emotional numbing and detachment from other people, and hyperarousal (irritability, insomnia, fearfulness, nervous agitation). PTSD is linked to structural neurochemical changes in the central nervous system which may have a direct

Post-traumatic stress disorder (PTSD) is a relatively new name for a condition that has bedeviled veterans of the military service members throughout the history of warfare. It has taken people around the world, especially within the military branches an exceptionally long time to understand and face the reality of a growing epidemic known as Post-Traumatic Stress Disorder (PTSD). The best and ideal starting point to understand PTSD would be by raising the question, what is PTSD? According to physiological explanation PTSD is an anxiety disorder that may develop after exposure to a terrifying event or ordeal in which severe physical harm occurred or was threatened. Traumatic events that may trigger PTSD include violent personal assaults, natural or unnatural disaster, accidents or military combat.

Post-traumatic stress disorder, PTSD is a psychiatric disorder that may develop after experiencing or seeing a traumatic or a brutal life threatening event. It is increasingly on the rise in war veterans. For those with PTSD only 53 percent have seen physicians or a mental health care provider. And for those who sought out care, roughly only 50 percent received adequate treatment when returning from combat. Although there are many treatments available most patients disregard the obvious signs of PTSD. Because some are afraid of the stigma of PTSD and being labeled as a crazy or violent person, If we create awareness and stop this ignorant notion, people with the disorder would

The NPH PMO provides advanced development support of clinical trials involving U.S. FDA-licensed drugs to treat the various symptom clusters of PTSD and trials to find solutions for mild and moderate to severe TBI. The NPH PMO monitors the pharmacotherapeutic horizon to seek novel opportunities with currently licensed as well as new drugs. The NPH staff also stays abreast of non-DoD clinical trials of new drugs to treat TBI and

The patients used it this design were outpatients referred in 1992 through 1995 by professionals, Victim Support, police, ambulance, fire services, and even the subjects themselves. The criteria that had to be met in order for the subjects to be used in this study were as followed: PTSD for 6 or more months; age of 16 to 65 years; and absence of melancholia or suicidal intent, organic brain disease, past or present psychosis, antidepressant drug (unless the patient had been receiving a stable dose for 3 or more months); and diazepam in a dose of 10 mg/d or more or equivalent, ingestion of 30 or more alcohol units a week, and past exposure or cognitive therapy for PTSD (Marks et al., 1998). The therapist used a procedure manual and 4 treatment manuals which covered each session in each treatment condition. The sessions were audiotaped and each individual session lasted either 90 minutes or 105 minutes in Exposure Combined with Cognitive Restructuring (EC) therapy.

A PubMed search was conducted to locate primary literature on the use of quetiapine as monotherapy in veterans with PTSD. Search terms used were “quetiapine”, “monotherapy” and “PTSD” to ensure appropriate studies were retrieved by the search.

Bates, B. (2010, March 15). PTSD, substance abuse best treated together. Internal Medicine News, 43(5), 55. Retrieved from http://go.galegroup.com.ezproxy.liberty.edu:2048/ps/i.do?id=GAL